Delivery Order SPE2DB22D3016-SPE2DB24FBGY9

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Trelegy Ellipta 100-62.5-25 60s pharmaceutical products. The contract has a ceiling value of $18,665.42 and is a firm fixed price delivery order with a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical pharmaceutical supplies to support military treatment facilities and other federal healthcare...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,659.73 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a ceiling value of $11,821.90 and a completion date of June 4, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The $77,568.28 firm-fixed-price delivery order contract has an ultimate completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $5,309.11. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 2, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a ceiling value of $24,402.92 and a completion date of April 1, 2025. The contract is a firm fixed-price type, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, with a ceiling value of $2,354.40 and a period of performance through April 15, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, over the period from February 3, 2025 to February 4, 2025. The contract has a ceiling value of $5,578.92 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any special program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $5,243.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a type of pharmaceutical product, with a completion date of June 20, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This federal contract award, valued at $6,123.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order for Firm Fixed Price procurement of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBGY9
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product. The contract has a ceiling value of $10,757.77 and an ultimate completion date of September 17, 2024. It is a delivery order contract, with a firm fixed price pricing type. The contract is not associated with any set-aside designation. AmerisourceBergen, through its Corporate Office division, will be responsible for providing the requested pharmaceutical product to support various military treatment facilities and federal healthcare programs under this contract award.

Generated 12/16/24, 2:34 PM